CD19 and ovarian carcinoma: The starting material for cell line BOC-78 was ovarian cancer ascites fluid (sample 22-78-Ascites, Table 2), consisting of mostly CD45+ inflammatory immune cells, including CD3+ T and CD19+ B lymphocytes, CD14+ monocyte/macrophages and CD56 NK cells (Figure 2C).